FDA Inspection
ARL Biopharma, Inc.ARL Biopharma, Inc. – FDA Inspection, Mar 25, 2016
Record Details
This FDA Inspection record concerns ARL Biopharma, Inc., with an inspection on March 25, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- ARL Biopharma, Inc.
- Inspection Date
- March 25, 2016
- Product Type
- Drugs
View Company Profile
ID · d5a8ac1d-9744-43f0-a76e-6727f2380fa5
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 965921
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of ARL Biopharma, Inc.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| May 22, 2026 | Not classified | Dallas District Office | |
| September 20, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 8, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 19, 2010 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 18, 2010 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for ARL Biopharma, Inc.
- FDA Inspection 1322550 - 2026-05-22
- FDA Inspection 1102393 - 2019-09-20
- FDA Inspection 806356 - 2012-11-08
- FDA Inspection 701726 - 2010-11-19
- FDA Inspection 651237 - 2010-02-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.